{
    "organizations": [],
    "uuid": "1dc3c03a1cd6883e7832e6a2958d9f1016ae52fb",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ptc-therapeutics-q4-revenue-780-mi/brief-ptc-therapeutics-q4-revenue-78-0-million-idUSFWN1QO0SM",
    "ord_in_thread": 0,
    "title": "BRIEF-PTC Therapeutics Q4 Revenue $78.0 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 6 (Reuters) - PTC Therapeutics Inc:\n* ‍TOTAL REVENUES FOR Q4 OF 2017 WERE $78.0 MILLION COMPARED TO $25.2 MILLION IN Q4 OF 2016​\n* SEES ‍FULL YEAR 2018 NET PRODUCT REVENUES TO BE BETWEEN $260 AND $295 MILLION​\n* ‍PTC ANTICIPATES TRANSLARNA NET PRODUCT REVENUE FOR FULL YEAR 2018 TO BE BETWEEN $170 AND $185 MILLION​\n* ‍PTC PROJECTS A 5-YEAR (DECEMBER 31, 2022) COMPOUND ANNUAL GROWTH RATE OF 15% FOR NET PRODUCT REVENUES​\n* ‍PTC ANTICIPATES EMFLAZA NET PRODUCT REVENUE FOR FULL YEAR 2018 TO BE BETWEEN $90 AND $110 MILLION​\n* QTRLY ‍SHR $ 0.03​ * Q4 REVENUE VIEW $74.4 MILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-07T05:18:00.000+02:00",
    "crawled": "2018-03-07T19:46:31.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "ptc",
        "therapeutic",
        "inc",
        "revenue",
        "q4",
        "million",
        "compared",
        "million",
        "q4",
        "see",
        "year",
        "net",
        "product",
        "revenue",
        "anticipates",
        "translarna",
        "net",
        "product",
        "revenue",
        "full",
        "year",
        "project",
        "december",
        "compound",
        "annual",
        "growth",
        "rate",
        "net",
        "product",
        "anticipates",
        "emflaza",
        "net",
        "product",
        "revenue",
        "full",
        "year",
        "qtrly",
        "q4",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}